ArticleSystematic reviews2026
How is shared decision making used in the treatment of patients with liver disease? a scoping review.
Article in Systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundShared decision making (SDM) is an approach in which healthcare providers and patients collaboratively consider the best available evidence when making treatment decisions; patients are also supported in evaluating available options and forming informed preferences. However, evidence regarding treatment decision making contexts involving SDM for patients with liver disease remains limited. Therefore, this scoping review analyzes the contextual environments in which SDM is implemented during the treatment of patients with liver disease and examines the characteristics of patient participation in the SDM process.
methodsThis study focused on treatment decision making contexts (context) involving SDM (concept) among patients with liver disease (population). Following the Arksey and O'Malley scoping review method, structured searches of articles published until March 2025 were conducted in four electronic databases: PubMed, Cumulative Index to Nursing and Allied Health Literature, Embase, and Web of Science. The search terms used were "shared decision making" and "liver disease." Eight studies were ultimately included in the review.
resultsSDM was applied in treatment contexts, including medication initiation, surgical decision making, and the selection of therapeutic approaches such as hepatic resection and radiofrequency ablation. Five (62.5%) out of the eight studies included surgery as an option, and four (50.0%) focused on patients with liver cancer. When the patients with liver disease participated in the SDM process, they were presented with treatment options, provided information about these options, and asked to express their preferences. However, only one study evaluated decision making outcomes.
conclusionsCancer-related and surgical decision making contexts were the most frequent targets for SDM in this review. However, patient decision aids (PDAs) are currently unavailable for any liver disease. Additionally, only one study included a process for re-evaluating prior decisions. Future research and clinical practice should incorporate mechanisms for re-evaluating prior decisions and support the development of PDAs for liver disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.